カテゴリー： Infiniti Research TechNavio, アジア太平洋, 医療/バイオ

体外診断用医薬品の中国市場2020年-2024年

【英語タイトル】China In-Vitro Diagnostics Market 2020-2024

Technavioが出版した調査資料（IRTNTR45878）・商品コード：IRTNTR45878
・発行会社（調査会社）：Technavio
・発行日：2020年12月8日
・ページ数：約120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：中国
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥325,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥390,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥520,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
テクナビオ社の本調査レポートでは、中国の体外診断用医薬品市場について調査し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別（免疫化学、組織診断、分子診断、血液内科、その他）分析、エンドユーザー別（病院、在宅医療、研究機関、独立研究所）分析、顧客状況、企業状況、企業分析などを掲載しております。
❖ レポートの概要 ❖

China in-vitro diagnostics market 2020-2024Technavio has been monitoring the China in-vitro diagnostics market and it is poised to grow by $ 6.93 bn during 2020-2024 progressing at a CAGR of 17% during the forecast period. Our reports on China in-vitro diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current china market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in incidences of chronic and infectious diseases, geriatric population in China and increase in adoption of POC testing. In addition, increase in incidences of chronic and infectious diseases is anticipated to boost the growth of the market as well.
The China in-vitro diagnostics market analysis includes the end-user segment and geographical landscapes.

Technavio’s China in-vitro diagnostics market is segmented as below:
By End-user
• Hospitals
• Homecare
• Research Institutes
• Independent Laboratories

By Application
• Immunochemistry
• Tissue Diagnostics
• Molecular Diagnostics
• Hematology
• Others

This study identifies the healthcare infrastructure expansion as one of the prime reasons driving the China in-vitro diagnostics market growth during the next few years. Also, continuous advances in IVD procedures and companion diagnostics will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our China in-vitro diagnostics market covers the following areas:
• China in-vitro diagnostics market sizing
• China in-vitro diagnostics market forecast
• China in-vitro diagnostics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading China in-vitro diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Autobio Diagnostics Co. Ltd., Bioptik Technology Inc., Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, and Sysmex Corp.. Also, the China in-vitro diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/china-in-vitro-diagnostics-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

❖ レポートの目次 ❖

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Immunochemistry – Market size and forecast 2019-2024
o Tissue diagnostics – Market size and forecast 2019-2024
o Molecular diagnostics – Market size and forecast 2019-2024
o Hematology – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by Application
• Market Segmentation by End-user
o Market segments
o Comparison by End user
o Hospitals – Market size and forecast 2019-2024
o Homecare – Market size and forecast 2019-2024
o Research institutes – Market size and forecast 2019-2024
o Independent laboratories – Market size and forecast 2019-2024
o Market opportunity by End user
• Customer landscape
o Overview
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Agilent Technologies Inc.
o Autobio Diagnostics Co. Ltd.
o Bioptik Technology Inc.
o Bio-Rad Laboratories Inc.
o Danaher Corp.
o F. Hoffmann-La Roche Ltd.
o Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
o Siemens Healthineers AG
o Sysmex Corp.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 5
• 4: Key Finding 6
• 5: Key Finding 7
• 6: Parent market
• 7: Market characteristics
• 8: Offerings of vendors included in the market definition
• 9: Market segments
• 10: Global – Market size and forecast 2019 – 2024 ($ million)
• 11: Global market: Year-over-year growth 2019 – 2024 (%)
• 12: Five forces analysis 2019 & 2024
• 13: Bargaining power of buyers
• 14: Bargaining power of suppliers
• 15: Threat of new entrants
• 16: Threat of substitutes
• 17: Threat of rivalry
• 18: Market condition – Five forces 2019
• 19: Application – Market share 2019-2024 (%)
• 20: Comparison by Application
• 21: Immunochemistry – Market size and forecast 2019-2024 ($ million)
• 22: Immunochemistry – Year-over-year growth 2019-2024 (%)
• 23: Tissue diagnostics – Market size and forecast 2019-2024 ($ million)
• 24: Tissue diagnostics – Year-over-year growth 2019-2024 (%)
• 25: Molecular diagnostics – Market size and forecast 2019-2024 ($ million)
• 26: Molecular diagnostics – Year-over-year growth 2019-2024 (%)
• 27: Hematology – Market size and forecast 2019-2024 ($ million)
• 28: Hematology – Year-over-year growth 2019-2024 (%)
• 29: Others – Market size and forecast 2019-2024 ($ million)
• 30: Others – Year-over-year growth 2019-2024 (%)
• 31: Market opportunity by Application
• 32: End user – Market share 2019-2024 (%)
• 33: Comparison by End user
• 34: Hospitals – Market size and forecast 2019-2024 ($ million)
• 35: Hospitals – Year-over-year growth 2019-2024 (%)
• 36: Homecare – Market size and forecast 2019-2024 ($ million)
• 37: Homecare – Year-over-year growth 2019-2024 (%)
• 38: Research institutes – Market size and forecast 2019-2024 ($ million)
• 39: Research institutes – Year-over-year growth 2019-2024 (%)
• 40: Independent laboratories – Market size and forecast 2019-2024 ($ million)
• 41: Independent laboratories – Year-over-year growth 2019-2024 (%)
• 42: Market opportunity by End user
• 43: Customer landscape
• 44: Impact of drivers and challenges
• 45: Vendor landscape
• 46: Landscape disruption
• 47: Industry risks
• 48: Vendors covered
• 49: Market positioning of vendors
• 50: Abbott Laboratories – Overview
• 51: Abbott Laboratories – Business segments
• 52: Abbott Laboratories – Key offerings
• 53: Abbott Laboratories – Key customers
• 54: Abbott Laboratories – Segment focus
• 55: Agilent Technologies Inc. – Overview
• 56: Agilent Technologies Inc. – Business segments
• 57: Agilent Technologies Inc. – Key offerings
• 58: Agilent Technologies Inc. – Key customers
• 59: Agilent Technologies Inc. – Segment focus
• 60: Autobio Diagnostics Co. Ltd. – Overview
• 61: Autobio Diagnostics Co. Ltd. – Product and service
• 62: Autobio Diagnostics Co. Ltd. – Key offerings
• 63: Autobio Diagnostics Co. Ltd. – Key customers
• 64: Autobio Diagnostics Co. Ltd. – Segment focus
• 65: Bioptik Technology Inc. – Overview
• 66: Bioptik Technology Inc. – Product and service
• 67: Bioptik Technology Inc. – Key offerings
• 68: Bioptik Technology Inc. – Key customers
• 69: Bioptik Technology Inc. – Segment focus
• 70: Bio-Rad Laboratories Inc. – Overview
• 71: Bio-Rad Laboratories Inc. – Business segments
• 72: Bio-Rad Laboratories Inc. – Key offerings
• 73: Bio-Rad Laboratories Inc. – Key customers
• 74: Bio-Rad Laboratories Inc. – Segment focus
• 75: Danaher Corp. – Overview
• 76: Danaher Corp. – Business segments
• 77: Danaher Corp. – Key offerings
• 78: Danaher Corp. – Key customers
• 79: Danaher Corp. – Segment focus
• 80: F. Hoffmann-La Roche Ltd. – Overview
• 81: F. Hoffmann-La Roche Ltd. – Business segments
• 82: F. Hoffmann-La Roche Ltd. – Key offerings
• 83: F. Hoffmann-La Roche Ltd. – Key customers
• 84: F. Hoffmann-La Roche Ltd. – Segment focus
• 85: Shenzhen Mindray Bio-Medical Electronics Co. Ltd. – Overview
• 86: Shenzhen Mindray Bio-Medical Electronics Co. Ltd. – Product and service
• 87: Shenzhen Mindray Bio-Medical Electronics Co. Ltd. – Key offerings
• 88: Shenzhen Mindray Bio-Medical Electronics Co. Ltd. – Key customers
• 89: Shenzhen Mindray Bio-Medical Electronics Co. Ltd. – Segment focus
• 90: Siemens Healthineers AG – Overview
• 91: Siemens Healthineers AG – Business segments
• 92: Siemens Healthineers AG – Key offerings
• 93: Siemens Healthineers AG – Key customers
• 94: Siemens Healthineers AG – Segment focus
• 95: Sysmex Corp. – Overview
• 96: Sysmex Corp. – Product and service
• 97: Sysmex Corp. – Key offerings
• 98: Sysmex Corp. – Key customers
• 99: Sysmex Corp. – Segment focus
• 100: Currency conversion rates for US$
• 101: Research Methodology
• 102: Validation techniques employed for market sizing
• 103: Information sources
• 104: List of abbreviations



❖ 掲載企業 ❖

Abbott Laboratories, Agilent Technologies Inc., Autobio Diagnostics Co. Ltd., Bioptik Technology Inc., Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, Sysmex Corp.

★調査レポート[体外診断用医薬品の中国市場2020年-2024年] (コード：IRTNTR45878)販売に関する免責事項を必ずご確認ください。
★調査レポート[体外診断用医薬品の中国市場2020年-2024年]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆